Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes-Reference-Cited by-同舟云学术

Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes

Published:2021-04 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Hensley Patrick J.,Bree Kelly K.,Brooks Nathan,Matulay Justin,Li Roger,Nogueras-Gonzalez Graciela M.,Nagaraju Supriya,Navai Neema,Grossman H. Barton,Dinney Colin P.,Kamat Ashish M.^ORCID

Funder

University of Texas MD Anderson Cancer Center

Urology Care Foundation

National Cancer Institute

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference20 articles.

1. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy;Herr;J Urol,2005

2. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)—2019 update;Babjuk;Eur Urol,2019

3. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

4. Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology;Flaig;J Natl Compr Canc Netw,2020

5. Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer;Bishr;Can Urol Assoc J,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

2. Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re‐staging TURBT and Intravesical Adjuvant Therapy;BJUI Compass;2024-04-17

3. The Effect of Second TURBT on Recurrence and Progression in Primary Ta High-grade Bladder Cancers: A Multicenter Clinical Trial Comparing Long-term Outcomes;The Bulletin of Urooncology;2023-03-01